Gencurix Inc - Asset Resilience Ratio

Latest as of June 2025: 4.01%

Gencurix Inc (229000) has an Asset Resilience Ratio of 4.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩1.08 Billion

≈ $730.31K USD Cash + Short-term Investments

Total Assets

₩26.90 Billion

≈ $18.23 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Gencurix Inc's Asset Resilience Ratio has changed over time. Check how strategically is Gencurix Inc's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Gencurix Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Gencurix Inc market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.08 Billion	4.01%
Total Liquid Assets	₩1.08 Billion	4.01%

Asset Resilience Insights

Limited Liquidity: Gencurix Inc maintains only 4.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Gencurix Inc Industry Peers by Asset Resilience Ratio

Compare Gencurix Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Clinica Baviera MC:CBAV	Diagnostics & Research	14.23%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Shanghai Labway Clinical Laboratory Co Ltd SHE:301060	Diagnostics & Research	2.10%
SCOPE FLUIDICS SA ZY-10 F:S84	Diagnostics & Research	32.55%
Optipharm.CO.LTD KQ:153710	Diagnostics & Research	18.64%
Predilife PA:ALPRE	Diagnostics & Research	16.23%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%

Annual Asset Resilience Ratio for Gencurix Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Gencurix Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	15.11%	₩4.54 Billion ≈ $3.08 Million	₩30.04 Billion ≈ $20.36 Million	-18.54pp
2023-12-31	33.65%	₩11.27 Billion ≈ $7.64 Million	₩33.50 Billion ≈ $22.70 Million	+17.65pp
2022-12-31	16.01%	₩5.96 Billion ≈ $4.04 Million	₩37.24 Billion ≈ $25.24 Million	-23.72pp
2021-12-31	39.73%	₩21.96 Billion ≈ $14.88 Million	₩55.29 Billion ≈ $37.47 Million	+30.93pp
2020-12-31	8.80%	₩5.63 Billion ≈ $3.81 Million	₩63.98 Billion ≈ $43.36 Million	-16.06pp
2019-12-31	24.85%	₩593.34 Million ≈ $402.10K	₩2.39 Billion ≈ $1.62 Million	-46.40pp
2018-12-31	71.25%	₩7.23 Billion ≈ $4.90 Million	₩10.14 Billion ≈ $6.87 Million	+9.81pp
2017-12-31	61.44%	₩4.52 Billion ≈ $3.07 Million	₩7.36 Billion ≈ $4.99 Million	-7.41pp
2016-12-31	68.85%	₩6.36 Billion ≈ $4.31 Million	₩9.23 Billion ≈ $6.26 Million	--

pp = percentage points

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$23.48 Million

₩34.65 Billion KRW

Market Cap Rank

#24530 Global

#1735 in Korea

Share Price

₩1479.00

Change (1 day)

-5.92%

52-Week Range

₩1428.00 - ₩5870.00

All Time High

₩23845.65